An interventional study of Oral peptones load in Hyperparathyroidism and Hypercalcemia, sponsored by University of Eastern Piedmont. Completed at 1 site in Italy. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-01-05.
Sponsored by University of Eastern Piedmont · Not applicable, Interventional, and Basic science
The purpose of this study is to assess if subjects with hyperparathyroidism with normal serum calcium levels have different responses in the calcium regulating hormonal handling compared to a) patients with primary hyperparathyroidism and high serum calcium levels; b) healthy subjects.
The differences will be evaluated with oral peptones load and subsequent blood samples collected every 15 minutes for two hours. Ionized calcium, phosphate, gastrin and PTH levels will be evaluated.
110 studies on the registry are indexed under Hyperparathyroidism; 12 are open to participants now.
This study's enrollment of 60 is above the median of 53 across 67 interventional studies indexed under Hyperparathyroidism.
Browse Hyperparathyroidism studies →University of Eastern Piedmont is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
normocalcemic hyperparathyroidism
hypercalcemic hyperparathyroidism
Exclusion Criteria:
Other: Oral peptones load
Other: Oral peptones load
Other: Oral peptones load
Enrolled subjects will receive 10 g Liebig meat extract diluted in 250ml of 0.9% saline
PTH levels variations
Time frame: 2 hours
Ionized serum calcium variations
Time frame: 2 hours
Serum phosphate variations
Time frame: 2 hours
Serum gastrin variations
Time frame: 2 hours
This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Eastern Piedmont